Novartis NVS reported its Q3 earnings results on Tuesday, October 25, 2022 at 01:00 AM.
Here's what investors need to know about the announcement.
Earnings
Novartis beat estimated earnings by 0.64%, reporting an EPS of $1.58 versus an estimate of $1.57.
Revenue was down $487.00 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.04 which was followed by a 2.07% drop in the share price the next day.
Here's a look at Novartis's past performance:
Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
---|---|---|---|---|
EPS Estimate | 1.52 | 1.44 | 1.42 | 1.65 |
EPS Actual | 1.56 | 1.46 | 1.40 | 1.71 |
Revenue Estimate | 13.01B | 12.73B | 13.30B | 13.03B |
Revenue Actual | 12.78B | 12.53B | 13.23B | 13.03B |
To track all earnings releases for Novartis visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.